Compounds > dichlorobis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)platinum (ii)
Page last updated: 2024-09-04

dichlorobis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)platinum (ii) and rhodium

dichlorobis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)platinum (ii) has been researched along with rhodium in 1 studies

Compound Research Comparison

Studies
(dichlorobis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)platinum (ii))		Trials
(dichlorobis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)platinum (ii))		Recent Studies (post-2010)
(dichlorobis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)platinum (ii))		Studies
(rhodium)		Trials
(rhodium)		Recent Studies (post-2010) (rhodium)
6003,25511,727

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, I; Chibber, R; Goodgame, D; Lee, B; Robbins, AB; Stratford, IJ1

Other Studies

1 other study(ies) available for dichlorobis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)platinum (ii) and rhodium

ArticleYear
Radiosensitization of mammalian cells by transition metal complexes containing nitroimidazole ligands.
    International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:8

    Topics: Animals; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Female; Metronidazole; Nitroimidazoles; Organometallic Compounds; Organoplatinum Compounds; Ovary; Radiation-Sensitizing Agents; Rhodium

1984